
Keywords: IVIg; Intravenous immunoglobulin; GBS; Guillain-Barré syndrome; CIDP; Chronic inflammatory demyelinating polyradiculoneuropathy; SIGN-R1; Specific ICAM3-grabbing nonintegrin related 1 receptor; sIVIg; α2,6 sialic acid enriched IVIg; uIVIg; α2,6 sialic